Tässä vuosien varrella on tullut luettua melko paljon tutkimuksia ja muita artikkeleita. Päätin koota tänne tietoa mm. kiinnostavista artikkeleista, webinaaritallenteista yms. Aion päivittää tätä listausta aika ajoin. 

Doshi P, Dickersin K, Healy D, Vedula S S, Jefferson T. (2013) Restoring invisible and abandoned trials: a call for people to publish the findings BMJ 2013;346:f2865.

Prayle A P, Hurley M N, Smyth A R. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study BMJ 2012;344:d7373.

Angell M. Industry-sponsored clinical research: a broken system. JAMA. 2008 Sep 3;300(9):1069-71.

Campbell EG, Weissman JS, Ehringhaus S, et al. Institutional academic-industry relationships. JAMA. 2007;298(15):1779-1786.

Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252-260.

The PLoS Medicine Editors (2009) Ghostwriting: The Dirty Little Secret of Medical Publishing That Just Got Bigger. PLoS Med 6(9): e1000156.

Jureidini J, McHenry L B. The illusion of evidence based medicine BMJ 2022; 376 :o702.

Jureidini J. Key opinion leaders in psychiatry: a conflicted pathway to career advancement. Aust N Z J Psychiatry. 2012 Jun;46(6):495-7.

Goldacre B, Lane S, Mahtani KR, Heneghan C, Onakpoya I, Bushfield I, Smeeth L. Pharmaceutical companies' policies on access to trial data, results, and methods: audit study. BMJ. 2017 Jul 26;358:j3334.

Ioannidis JPA (2014) How to Make More Published Research True. PLoS Med 11(10): e1001747.

Ioannidis JP. Evidence-based medicine has been hijacked: a report to David Sackett. J Clin Epidemiol. 2016 May;73:82-6.

Smith R. Peer review: a flawed process at the heart of science and journals. J R Soc Med. 2006 Apr;99(4):178-82.

Shorter E. Psychiatry and fads: why is this field different from all other fields? Can J Psychiatry. 2013 Oct;58(10):555-9.

Ioannidis JPA (2005) Why Most Published Research Findings Are False. PLoS Med 2(8): e124.

Lundh A, Barbateskovic M, Hróbjartsson A, Gøtzsche PC. Conflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort study. PLoS Med. 2010 Oct 26;7(10):e1000354.

John P. A. Ioannidis (2019) What Have We (Not) Learnt from Millions of Scientific Papers with P Values?, The American Statistician, 73:sup1, 20-25.

Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2017 Feb 16;2(2):MR000033.

Fava GA: Rational use of antidepressant drugs. Psychother Psychosom 2014; 83: 197–204.

Offidani E, Fava GA, Sonino N: Iatrogenic comorbidity in childhood and adolescence: new insights from the use of antidepressant drugs. CNS Drugs 2014; 28: 769–774.

Davies J, Read J. A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addict Behav. 2019 Oct;97:111-121.

Cartwright C, Gibson K, Read J, Cowan O, Dehar T. Long-term antidepressant use: patient perspectives of benefits and adverse effects. Patient Prefer Adherence. 2016 Jul 28;10:1401-7.

Eveleigh, R. (2015). Inappropriate long-term antidepressant use in primary care: A challenge to change (PhD thesis). Nijmegen: Radboud University.

Kondro W, Sibbald B. Drug company experts advised staff to withhold data about SSRI use in children. CMAJ. 2004;170(5):783.

Heres S, Davis J, Maino K, Jetzinger E, Kissling W, Leucht S. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics. Am J Psychiatry. 2006 Feb;163(2):185-94.

Lacasse JR, Leo J (2005) Serotonin and depression: A disconnect between the advertisements and the scientifi c literature. PLoS Med 2(12): e392.

Healy, D. (2006). The antidepressant tale: Figures signifying nothing? Advances in Psychiatric Treatment, 12(5), 320-327.

Ioannidis, J.P. Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?. Philos Ethics Humanit Med 3, 14 (2008).

Goldberg D, Privett M, Ustun B, Simon G, Linden M. The effects of detection and treatment on the outcome of major depression in primary care: a naturalistic study in 15 cities. Br J Gen Pract. 1998 Dec;48(437):1840-4.

Hengartner MP. Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants' Efficacy and Harm. Front Psychiatry. 2017 Dec 7;8:275.

Hengartner MP. How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding. Ther Adv Psychopharmacol. 2020 May 8;10:2045125320921694.

Kirsch, I. & Sapirstein, G. (1998) Listening to prozac but hearing placebo: a meta-analysis of antidepressant medication. Prevention & Treatment, 1, Article 0002a.

Jakobsen JC, Katakam KK, Schou A, Hellmuth SG, Stallknecht SE, Leth-Møller K, Iversen M, Banke MB, Petersen IJ, Klingenberg SL, Krogh J, Ebert SE, Timm A, Lindschou J, Gluud C. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. BMC Psychiatry. 2017 Feb 8;17(1):58.

Tässä webinaaritallenteessa psykiatri Joanna Moncrieff käy läpi mm. psykooseihin ja psykoosilääkkeisiin liittyviä myyttejä (esim. myytti siitä, että psykoosi/skitsofrenia on etenevä aivosairaus).